463 related articles for article (PubMed ID: 31734639)
41. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
42. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
[TBL] [Abstract][Full Text] [Related]
43. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
[No Abstract] [Full Text] [Related]
44. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
45. Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score.
Brancato V; Cerrone M; Garbino N; Salvatore M; Cavaliere C
World J Gastroenterol; 2024 Jan; 30(4):381-417. PubMed ID: 38313230
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of multi-parametric breast MR imaging for predicting pathological complete response of operable breast cancer prior to neoadjuvant systemic therapy.
Tsukada H; Tsukada J; Schrading S; Strobel K; Okamoto T; Kuhl CK
Magn Reson Imaging; 2019 Oct; 62():242-248. PubMed ID: 31352016
[TBL] [Abstract][Full Text] [Related]
47. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
[TBL] [Abstract][Full Text] [Related]
48. Overview of radiomics in breast cancer diagnosis and prognostication.
Tagliafico AS; Piana M; Schenone D; Lai R; Massone AM; Houssami N
Breast; 2020 Feb; 49():74-80. PubMed ID: 31739125
[TBL] [Abstract][Full Text] [Related]
49. Breast MRI radiomics and machine learning-based predictions of response to neoadjuvant chemotherapy - How are they affected by variations in tumor delineation?
Hatamikia S; George G; Schwarzhans F; Mahbod A; Woitek R
Comput Struct Biotechnol J; 2024 Dec; 23():52-63. PubMed ID: 38125296
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic accuracy of radiomics-based machine learning for neoadjuvant chemotherapy response and survival prediction in gastric cancer patients: A systematic review and meta-analysis.
Adili D; Mohetaer A; Zhang W
Eur J Radiol; 2024 Apr; 173():111249. PubMed ID: 38382422
[TBL] [Abstract][Full Text] [Related]
51. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).
van der Noordaa MEM; van Duijnhoven FH; Loo CE; van Werkhoven E; van de Vijver KK; Wiersma T; Winter-Warnars HAO; Sonke GS; Vrancken Peeters MTFD
Breast; 2018 Aug; 40():76-81. PubMed ID: 29698928
[TBL] [Abstract][Full Text] [Related]
52. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
53. PET/CT radiomics in breast cancer: Mind the step.
Sollini M; Cozzi L; Ninatti G; Antunovic L; Cavinato L; Chiti A; Kirienko M
Methods; 2021 Apr; 188():122-132. PubMed ID: 31978538
[TBL] [Abstract][Full Text] [Related]
54. Integration of Clinical and CT-Based Radiomic Features for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Breast Cancer.
Tsai HY; Tsai TY; Wu CH; Chung WS; Wang JC; Hsu JS; Hou MF; Chou MC
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551746
[TBL] [Abstract][Full Text] [Related]
55. Prostate MRI radiomics: A systematic review and radiomic quality score assessment.
Stanzione A; Gambardella M; Cuocolo R; Ponsiglione A; Romeo V; Imbriaco M
Eur J Radiol; 2020 Aug; 129():109095. PubMed ID: 32531722
[TBL] [Abstract][Full Text] [Related]
56. Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score.
Sanduleanu S; Woodruff HC; de Jong EEC; van Timmeren JE; Jochems A; Dubois L; Lambin P
Radiother Oncol; 2018 Jun; 127(3):349-360. PubMed ID: 29779918
[TBL] [Abstract][Full Text] [Related]
57. Metabolic Radiomics for Pretreatment
Ha S; Park S; Bang JI; Kim EK; Lee HY
Sci Rep; 2017 May; 7(1):1556. PubMed ID: 28484211
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
Kang DK; Kim TH; Han TS; Kim KS; Yim H
J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
[TBL] [Abstract][Full Text] [Related]
59. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
